Greater CTSS Levels May Be Linked To Higher IgAN Risk, Research Suggests
July 12, 2024
HCPlive (7/11, Brooks) reports, “Greater levels of cathepsin S (CTSS) may be associated with an increased risk of IgA nephropathy (IgAN), according to findings from a recent study.” The findings “highlight a significant upregulation of CTSS in the serum and renal tissues of patients with IgAN, suggesting CTSS may serve as a viable diagnostic and prognostic biomarker and could present a promising pathway for developing effective IgAN therapies.” The findings were published in Frontiers in Immunology.